Profil
Seung-Hwan Lee served as an Independent Director at GenoFocus, Inc. and as a Non-Executive Director at i3system, Inc. Prior to that, he worked as a Senior Investment Analyst at Mirae Asset Global Investments Co., Ltd. Lee received his undergraduate degree from Peking University in 2003.
Anciens postes connus de Seung-Hwan Lee
| Sociétés | Poste | Fin |
|---|---|---|
| HLB GENEX, INC. | Directeur/Membre du Conseil | - |
| I3SYSTEM INC. | Directeur/Membre du Conseil | - |
Mirae Asset Global Investments Co., Ltd.
Mirae Asset Global Investments Co., Ltd. Investment ManagersFinance Mirae Asset performs bottom-up research, aiming to identify the sustainable competitiveness of companies (a commanding market share, comparative advantages to competitors, a differentiated business model and high levels of transparency and corporate governance). They assess investment risk with expected return and monitor valuations, liquidity and corporate governance for their potential to inflict damage on long-term competitiveness. The firm constructs portfolios following a team-based approach to decision making, with extensive discussion and a firm commitment to adhere to their investment principles and process. | Analyst-Equity | - |
Formation de Seung-Hwan Lee
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirae Asset Global Investments Co., Ltd.
Mirae Asset Global Investments Co., Ltd. Investment ManagersFinance Mirae Asset performs bottom-up research, aiming to identify the sustainable competitiveness of companies (a commanding market share, comparative advantages to competitors, a differentiated business model and high levels of transparency and corporate governance). They assess investment risk with expected return and monitor valuations, liquidity and corporate governance for their potential to inflict damage on long-term competitiveness. The firm constructs portfolios following a team-based approach to decision making, with extensive discussion and a firm commitment to adhere to their investment principles and process. | Finance |
GenoFocus, Inc.
GenoFocus, Inc. BiotechnologyHealth Technology Develops, manufactures and sells enzyme and fermentation products | Health Technology |
i3system, Inc.
i3system, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells infrared and x-ray sensors | Health Technology |
















